A randomized controlled trial comparing Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia with treatment refractory hallucinations
A randomized controlled trial comparing Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia with treatment refractory hallucinations
一项随机对照试验，比较阿凡达疗法与认知行为疗法治疗难治性幻觉的精神分裂症
批准号：
380814
负责人：
Dumais Alexandre
金额：
$47.32万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-03-01 至 2024-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Schizophrenia is associated with long-lasting health, social and financial burden for patients, families, caregivers and society. According to the World Health Organization, this burdensome illness is one of the top 10 causes of disability in developed co
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A randomized controlled trial comparing Virtual Reality Therapy to Supportive Therapy to reduce cannabis use in patients with psychotic disorders
-
批准号：462127
-
项目类别：Operating Grants
-
资助金额：$51.27万
-
财政年份：2022
-
负责人：Dumais Alexandre
-
依托单位：
Innovative virtual reality-based psychotherapy for the treatment of cannabis use disorder in patients with psychotic disorders.
-
批准号：441603
-
项目类别：Operating Grants
-
资助金额：$0.0万
-
财政年份：2020
-
负责人：Dumais Alexandre
-
依托单位：
海外基金
